Curaleaf Holdings CURA CURLF filed its application to list the company's subordinate voting shares on the Toronto Stock Exchange (TSX).
As previously announced, the cannabis company completed a marketed offering of subordinate voting shares on October 3, 2023 in order to satisfy a condition required for a potential listing on the TSX.
"We are pleased to announce we have submitted our listing application to the TSX," stated executive chairman Boris Jordan. "I believe uplisting to the TSX will provide greater access to a broader set of global institutional investors, offer custody solutions backed by U.S. financial institutions, reduce volatility in our stock by having dedicated market makers, and make Curaleaf available for inclusion into indexes such as TSX and MSCI, all to the benefit of our stakeholders. We continually manage the business with the best interest of the company in mind, and filing our application with the TSX is yet another step in that direction."
The listing of the subordinate voting shares on the TSX remains subject to the review of the TSX and is contingent on the satisfaction of all listing and regulatory requirements. There is no assurance that the TSX will approve the listing application or that the company will complete the listing on the TSX as currently proposed.
Price Action
Curaleaf shares closed Monday market session 1.78% higher at $4.3 per share.
Related Links:
Aurora And Curaleaf Cannabis Companies Each Close Multi-Million Dollar Funding Deals
'Corporate Behemoths' Are Behind Lawsuits Hindering New York's Cannabis Rollout, Says State Senator
EXCLUSIVE: Curaleaf's Boris Jordan Puts Premium On Cannabis Quality, Says 'We Want To Be The Best'
Photo: Courtesy of Kindel Media via Pexels
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.